InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Saturday, 12/05/2020 1:11:03 PM

Saturday, December 05, 2020 1:11:03 PM

Post# of 16706
66M cases worldwide with 700k new cases a day, 42M recovered and 1.5M sadly deceased with 12K+ a day, leaving a tragic 22M not recovered and this is apparently the possible current market for a successful and safe Treatment. IMO.
Vaccines to be starting next year so continued increases in cases is expected for some time...
Many are concerned about taking vaccines.
Many still dont social distance or wear defensive/preventive masks, especially in the USA it seems, causing continued future infections.
World wide licensing for production through a Big Pharma seems the best way to distribute enough to all the places where it is needed.
Say 10% to 30% or more will want a pill with effective results compared to tough and/or expensive infusion courses or a semi effective (at best) drug like REM. JMHO.
The safety record implies that Ifenprodil can possibly be given as an outpatient medicine for the earlier cases not yet hospitalized. There is also a possible use for recovering patients with lung damage for the ARDS/IPF issues many suffer after basic recovery.
Lastly, CEO CM discussed the questions about a COVID 20-21 etc that current vaccines probably wont be effective against. There will be continued need for Treatments.
I feel Good about this investment for several strong reasons...GLTA...